GENETICALLY ENGINEERED POLYPEPTIDES AND USE THEREOF Russian patent published in 2024 - IPC C07K16/00 C07K16/10 A61K39/00 

Abstract RU 2822498 C2

FIELD: biotechnology.

SUBSTANCE: group of inventions relates to biotechnology. Presented are: an antibody molecule containing CH2 and CH3 Fc domains, where the specified CH2 and CH3 Fc domains contain mutations, as well as a method for its preparation and application of this antibody molecule in the manufacture of a drug for the treatment of a disorder in a subject. In addition, a pharmaceutical composition for the treatment of a disorder has been disclosed, where said disorder is associated with an antigen that specifically binds to said antibody molecule, a nucleic acid molecule encoding an antibody molecule, a vector for the expression of an antibody molecule and a cell for producing an antibody molecule. A set for the treatment of a disorder, a method for treating a disorder, where the method includes injecting an effective amount of an antibody molecule to a subject in need, and a method for detecting a molecule specifically bound by an antibody molecule, are also described.

EFFECT: invention is used to treat a disorder in a subject where the specified disorder is associated with an antigen that specifically binds to the specified antibody molecule.

20 cl, 30 dwg, 2 tbl, 16 ex

Similar patents RU2822498C2

Title Year Author Number
Fc OPTIONS WITH INCREASED FcRn BINDING AND PROLONGED HALF-LIFE 2019
  • Qiu, Huawei
  • Mackness, Brian
RU2795592C2
Fc-VERSIONS WITH ALTERED BINDING WITH FcRn 2008
  • Chemberlen Aaron
  • Dakh'Jat Bassil
  • Dez'Jarlejs Dzhon Rudol'F
  • Karki Sher Bakhadur
RU2517621C2
VARIANTS OF Fc-REGION WITH IMPROVED ABILITY TO BIND TO PROTEIN A 2015
  • Shlotauer Tilman
RU2698969C2
Fc-VERSIONS WITH CHANGED BINDING WITH FcRn 2005
  • Chemberlen Aaron Kit
  • Disdzharlejs Dzhon R.
  • Karki Sher Bakhadur
  • Lazar Gregori Alan
  • Fil'Metter Just
  • Joder Shon Kristofer
RU2412200C2
POLYPEPTIDE VARIANTS WITH CHANGED EFFECTOR FUNCTION 2005
  • Loumehn Genri B.
  • Adams Kamellija V.
  • Marvin Dzhonatan S.
  • Lin Samanta
  • Mehn Juj-Tszjuj G.
RU2367667C2
IN VITRO PREDICTION OF ANTIBODY HALF-LIFE IN VIVO 2015
  • Emrikh Tomas
  • Kettenberger Gubert
  • Shlotauer Tilman
  • Shokh Angela
RU2688349C2
EMBODIMENTS OF Fc-REGION WITH MODIFIED BINDING PROPERTIES OF FcRn AND PROTEIN A 2015
  • Shlotauer Tilman
RU2713131C1
Fc VERSIONS WITH MODIFIED BINDING WITH FcRn 2008
  • Chemberlen Aaron
  • Dakh'Jat Bassil
  • Dez'Jarlejs Dzhon Rudolf
  • Karki Sher Bakhadur
  • Lazar Gregori Alan
RU2529951C2
VARIANTS OF Fc WITH CHANGED BINDING WITH FcRn 2014
  • Chemberlen Aaron
  • Dakhyat Bassil
  • Dezyarlejs Dzhon Rudolf
  • Karki Sher Bakhadur
  • Lazar Gregori Alan
RU2700882C2
METHOD FOR SELECTION AND OBTAINING OF HIGHLY SELECTIVE AND MULTISPECIFIC TARGETING GROUPS WITH SPECIFIED PROPERTIES, INCLUDING AT LEAST TWO DIFFERENT BINDING GROUPS, AND THEIR APPLICATIONS 2013
  • Fenn Sebastyan
  • Kopetski Erkhard
  • Tifentaler Georg
RU2639287C2

RU 2 822 498 C2

Authors

Viswanathan, Karthik

Ramakrishnan, Boopathy

Booth, Brian

Narayan, Kristin

Wollacott, Andrew, M.

Dates

2024-07-08Published

2017-08-02Filed